UBS’s Molecular Templates, Inc. MTEM Stock Holding History

UBS’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$2K	Hold	3	–	–	﹤0.01%	10038
2014 Q2	$2K	Hold	3	–	–	﹤0.01%	10086
2014 Q1	$2K	Sell	3 -6	-67%	-$4.87K	﹤0.01%	10079
2013 Q4	$7K	Buy	9 +3	+50%	+$2.26K	﹤0.01%	9353
2013 Q3	$5K	Hold	6	–	–	﹤0.01%	9445
2013 Q2	$5K	Buy	+6	New	+$5.07K	﹤0.01%	9276

Other funds holding MTEM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS's MTEM Position: Q3 2014 in Review

UBS increased its Molecular Templates, Inc. (MTEM) stake by 1,400% in Q3 2014, buying an estimated $349K and bringing the position to 540 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #4708.

UBS first reported a position in MTEM in Q2 2013 and has held it in 6 quarters since. 92 funds tracked by Wall St. Rank hold MTEM as of Q3 2014.

UBS held 540 shares of Molecular Templates, Inc. worth $321K as of Q3 2014.
UBS bought 504 Molecular Templates, Inc. shares in Q3 2014, an estimated $349K.
Molecular Templates, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4708 holding.
UBS first reported a position in Molecular Templates, Inc. in Q2 2013 and has held it in 6 quarters since.
92 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.